Description: Applied Molecular Transport Inc. develops biological therapeutics to treat autoimmune, metabolic, and inflammatory diseases.. The company develops submucosal biopharmaceuticals and bio-betters. Applied Molecular Transport Inc. was incorporated in 2010 and is based in South San Francisco, California.
Home Page: www.appliedmt.com
AMTI Technical Analysis
450 East Jamie Court
South San Francisco,
CA
94080
United States
Phone:
650 392 0420
Officers
| Name | Title |
|---|---|
| Mr. Graham K. Cooper | Exec. Chairman |
| Dr. Tahir Mahmood Ph.D. | Co-Founder, CEO & Director |
| Mr. Shawn M. Cross | Pres & COO |
| Dr. Randall Mrsny Ph.D. | Co-Founder & Director |
| Mr. Brandon Hants | Chief Financial Officer |
| Dr. Bittoo Kanwar M.D. | Chief Medical Officer |
| Mr. Douglas A. Rich M.B.A, M.B.A. | Chief Technical Officer |
| Mr. Andrew H. Chang | Head of Investor Relations & Corp. Communications |
| Mr. Earl M. Douglas | Exec. VP & Gen. Counsel |
| Dr. Andy Whitney Ph.D. | Sr. VP of Research & Translational Science |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5961 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-06-05 |
| Fiscal Year End: | December |
| Full Time Employees: | 125 |